Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden · Delayed Price · Currency is SEK 5.00
+0.02 (0.40%)
Mar 23, 2026, 12:10 PM CET
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 1.97 billion as of March 23, 2026. Its market cap has increased by 24.50% in one year.
Market Cap
1.97B
Enterprise Value
1.83B
Revenue
62.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.00
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 1.97B, an increase of 775.05%. That is a compound annual growth rate of 15.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.97B | -6.74% |
| Dec 30, 2025 | 2.11B | -16.09% |
| Dec 30, 2024 | 2.51B | 54.03% |
| Dec 29, 2023 | 1.63B | 7.15% |
| Dec 30, 2022 | 1.52B | 37.56% |
| Dec 30, 2021 | 1.11B | -10.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 2.99B |
| Flerie AB | 2.76B |
| Vicore Pharma Holding AB | 2.67B |
| Saniona AB | 2.08B |
| Diamyd Medical AB | 1.87B |
| BioInvent International AB | 1.43B |
| Medivir AB | 1.16B |
| Xspray Pharma AB | 1.11B |